CCRM Australia and Israeli Network for Advanced Cell Applications lay the foundation for international collaboration in regenerative medicine

The Centre for Commercialization of Regenerative Medicine Australia (CCRM Australia) is proud to partner with the Israeli Network for Advanced Cell Applications (INACA) to advance the commercialisation of cell applications locally and globally jointly. A memorandum of understanding has been signed on the 10th December during the Victoria-Israel Lifesciences Symposium of the Bioforum Summit 2018 in Tel Aviv.

Israel is at the forefront of cell and gene therapy research, punching well above its weight in global terms, with a vibrant scientific and industrial community. 4% of Israel’s GDP has been invested in civilian research and development, with a focus on biomedical research. The fruits of this investment are seen today with products strongly emerging through translation and towards successful commercial development and patient access.

Australia has a vibrant and world-class cellular therapy eco-system and is internationally recognised basic and translational research. Australia is also an ideal location for clinical trials, boasting an efficient Clinical Trial Notification process and a favourable R&D tax incentive. Thus, Australia is positioned well to serve as an innovation hub and a perfect partner for global companies seeking to accelerate their development and commercialisation activities.

The memorandum lays the foundation for joint commercialisation programs between the networks in Australia and Israel. The scope promotes collaborations in research and joint applications to support the international translation of advanced cell therapies, and education, which encourages doctoral student exchanges and fellowships.

CCRM Australia’s CEO Silvio Tiziani noted, “as the first hub of the CCRM global network, CCRM Australia is proud to support the development of other hubs in leading regenerative medicine countries such as Israel. The establishment of INACA forms an integral role in the CCRM Israel hub. We look forward to working with INACA and providing a conduit for INACA members to the Australian regenerative medicine sector and vice versa.”

Bioforum’s CEO and INACA board member, Yehudith Wexler commented “INACA is privileged to follow the footsteps of CCRM Australia, as part of the CCRM global network. The Israeli RM community is seeking to collaborate with the Australian scientists, developers, service providers, regulators and industry members in order to make products available for the public as soon as possible. The partnership declared is yet another step in enhancing the ties between us to advance our shared goals. ”

The signing of the memorandum is symbolic for the CCRM network as Israel moves towards establishing a local CCRM Hub. This agreement reflects the first commitment of any CCRM Hubs to collaborate to advance the translation and commercialisation of regenerative medicine.


About CCRM Australia

CCRM Australia is an Australian not-for-profit organisation supporting the development of foundational technologies to accelerate the commercialisation of regenerative medicine products and therapies. CCRM Australia’s focus is to bridge the commercialisation gap through a network of scientists, entrepreneurs, academic institutions and industry partners and address bottlenecks in the industry. CCRM Australia is modelled on the highly successful CCRM in Canada and is legally separate to CCRM. As a member of the Global CCRM network, CCRM Australia is a partner to a leading-edge industry consortium. CCRM Australia is supported by MTPConnect and the Victorian State Government.

About the Israeli Network for Advanced Cell Applications

The Israeli Industry Network for Advanced Cell Applications was established in early 2018 as part of the effort to bring different players within Israel to promote mutual discussion and collaboration in advanced cell therapies (cell therapy, gene therapy, gene-modified cells and tissue-regeneration products). INACA has at least 30 companies and hospital-based establishments, engaged in activities such as product development and clinical applications. Other members include service providers and regulatory bodies. This effort aims to further advance the field of Advanced Cell Applications in Israel and to expose it to global trends. INACA will collaborate with the global network of CCRM, which serves as a global hub for regenerative medicine expertise.

For more information, please contact:

CCRM Australia:

Erick Villaceran
erick.villaceran@ccrmaustralia.com.au